Form 4 Tracker
Enliven Therapeutics, Inc.
ELVN

27 insider filings · Latest: Jun 22, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 9, 2026Jan 9 9:49 PMKintz Samuel
Proposed Sale
75,000$23.25$1.7M

View →

Jan 9, 2026Jan 9 9:18 PMPatel Anish
Proposed Sale
48,300$23.25$1.1M

View →

Jan 8, 2026Jan 8 9:42 PMKintz Samuel
Proposed Sale
82,500$15.47$1.3M

View →

Jan 8, 2026Jan 8 9:26 PMLyssikatos Joseph P
Proposed Sale
82,500$15.47$1.3M

View →

Jan 8, 2026Jan 8 9:26 PMHeyman Richard A.
Proposed Sale
1,620$15.47$25.1K

View →

Jan 8, 2026Jan 8 9:18 PMHeyman Richard A.
Proposed Sale
12,300$15.47$190.3K

View →

Dec 19, 2025Dec 19 9:32 PMLyssikatos Joseph P
Proposed Sale
5,000$16.68$83.4K

View →

Dec 17, 2025Dec 17 9:23 PMKintz Samuel
Proposed Sale
5,000$16.91$84.5K

View →

Dec 8, 2025Dec 8 9:18 PMPatel Anish
Proposed Sale
6,663$21.81$145.3K

View →

Nov 19, 2025Nov 19 9:05 PMLyssikatos Joseph P
Proposed Sale
12,500$22.59$282.4K

View →

Nov 17, 2025Nov 17 9:16 PMKintz Samuel
Proposed Sale
12,500$22.07$275.9K

View →

Oct 20, 2025Oct 20 8:10 PMLyssikatos Joseph P
Proposed Sale
12,500$21.41$267.6K

View →

Oct 17, 2025Oct 17 8:16 PMKintz Samuel
Proposed Sale
12,500$21.75$271.9K

View →

Sep 29, 2025Sep 29 9:19 PMHohl Benjamin
Proposed Sale
4,500$20.01$90.0K

View →

Sep 19, 2025Sep 19 9:32 PMLyssikatos Joseph P
Proposed Sale
12,500$19.93$249.1K

View →

Sep 17, 2025Sep 17 8:08 PMKintz Samuel
Proposed Sale
12,500$18.43$230.4K

View →

Sep 8, 2025Sep 8 8:30 PMPatel Anish
Proposed Sale
20,001$20.15$403.0K

View →

Aug 27, 2025Aug 27 8:44 PMHohl Benjamin
Proposed Sale
5,250$20.32$106.7K

View →

Aug 19, 2025Aug 19 8:24 PMLyssikatos Joseph P
Proposed Sale
12,500$19.75$246.9K

View →

Aug 18, 2025Aug 18 8:21 PMKintz Samuel
Proposed Sale
12,500$20.22$252.8K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 17, 2026Jun 22 9:13 PMBenjamin HohlCHIEF FINANCIAL OFFICER
Option Exercise
6,018$2.4886,038(D)

View →

Jun 17, 2026Jun 22 9:11 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48121,268(D)

View →

May 18, 2026May 20 8:18 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48126,268(D)

View →

Apr 17, 2026Apr 22 12:40 AMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48131,268(D)

View →

Mar 25, 2026Mar 27 8:57 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
40,000$2.48136,268(D)

View →

Mar 17, 2026Mar 19 9:50 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48176,268(D)

View →

Mar 10, 2026Mar 11 9:32 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
10,129$2.48181,268(D)

View →

Mar 9, 2026Mar 11 9:32 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
29,871$2.48191,397(D)

View →

Feb 17, 2026Feb 19 11:36 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
45,000$2.48221,268(D)

View →

Feb 12, 2026Feb 18 1:01 AMLori Anne KunkelDirector
Grant/Award
17,126$27.1617,126(D)

View →

Feb 12, 2026Feb 18 1:00 AMRichard A. HeymanDirector
Grant/Award
19,234$27.1619,234(D)

View →

Feb 12, 2026Feb 18 12:59 AMRishi GuptaDirector
Grant/Award
35,569$27.161,580(D)

View →

Feb 12, 2026Feb 18 12:57 AMScott J. GarlandDirector
Grant/Award
1,427$27.161,427(D)

View →

Feb 12, 2026Feb 18 12:56 AMMika K DerynckDirector
Grant/Award
17,126$27.1617,126(D)

View →

Feb 12, 2026Feb 18 12:56 AMJake BauerDirector
Grant/Award
17,126$27.1617,126(D)

View →

Feb 12, 2026Feb 18 12:55 AMRahul D. BallalDirector
Grant/Award
17,126$27.1617,126(D)

View →

Feb 12, 2026Feb 18 12:53 AMAnish PatelCHIEF OPERATING OFFICER
Grant/Award
120,000$27.16120,000(D)

View →

Feb 12, 2026Feb 18 12:52 AMJoseph P LyssikatosCHIEF SCIENTIFIC OFFICER
Grant/Award
112,500$27.16112,500(D)

View →

Feb 12, 2026Feb 18 12:49 AMBenjamin HohlCHIEF FINANCIAL OFFICER
Grant/Award
150,000$27.16150,000(D)

View →

Feb 12, 2026Feb 18 12:47 AMHelen Louise CollinsCHIEF MEDICAL OFFICER
Grant/Award
150,000$27.16150,000(D)

View →